Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - Results of the eLEcTRA trial

DSpace Repository

Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - Results of the eLEcTRA trial

Author: Huober, J.; Fasching, P. A.; Barsoum, M.; Petruzelka, L.; Wallwiener, D.; Thomssen, C.; Reimer, T.; Paepke, S.; Azim, H. A.; Ragosch, V.; Kubista, E.; Baumgaertner, A. K.; Beckmann, M. W.; May, C.; Nimmrich, I.; Harbeck, N.
Tübinger Autor(en):
Huober, Jens
Wallwiener, Diethelm
Published in: Breast (2012), Bd. 21, H. 1, S. 27-33
Verlagsangabe: Churchill Livingstone
Language: English
Full text: http://dx.doi.org/10.1016/j.breast.2011.07.006
ISSN: 0960-9776
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)